Estudo randomizado | Em pessoas vivendo com HIV, o tratamento de lesões anais pré-cancerosas reduz mais da metade do risco de câncer anal.

Comunicado de imprensa: In people with HIV, treating precancerous anal lesions cuts risk of anal cancer by more than half – National Institutes of Health

Estudo original: Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer – New England Journal of Medicine (link para o resumo – $ para o texto completo)

Comentário no Twitter

Randomized trial showed that treating anal high-grade squamous intraepithelial lesions (HSILs) led to a 57% reduction in progression to anal cancer as compared with active surveillance. https://t.co/iulcskP61C pic.twitter.com/Q6Oqty3hgW

— NEJM (@NEJM) June 15, 2022